Tekla Capital Management as of March 31, 2017
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 139 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Gilead Sciences (GILD) | 6.7 | $172M | 2.5M | 67.92 | |
Celgene Corporation | 6.6 | $170M | 1.4M | 124.43 | |
Biogen Idec (BIIB) | 5.1 | $133M | 485k | 273.42 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 4.4 | $113M | 1.0M | 109.35 | |
Amgen (AMGN) | 4.4 | $112M | 685k | 164.07 | |
Alexion Pharmaceuticals | 3.7 | $97M | 796k | 121.24 | |
Incyte Corporation (INCY) | 3.6 | $93M | 693k | 133.67 | |
Johnson & Johnson (JNJ) | 3.5 | $89M | 714k | 124.55 | |
Merck & Co (MRK) | 3.0 | $76M | 1.2M | 63.54 | |
Allergan | 2.9 | $74M | 311k | 238.92 | |
Regeneron Pharmaceuticals (REGN) | 2.8 | $73M | 188k | 387.51 | |
Mylan Nv | 2.3 | $61M | 1.6M | 38.99 | |
Abbott Laboratories (ABT) | 2.0 | $51M | 1.2M | 44.41 | |
Illumina (ILMN) | 2.0 | $51M | 297k | 170.64 | |
UnitedHealth (UNH) | 1.9 | $50M | 307k | 164.01 | |
Medtronic (MDT) | 1.9 | $49M | 613k | 80.56 | |
Jazz Pharmaceuticals (JAZZ) | 1.9 | $48M | 331k | 145.13 | |
BioMarin Pharmaceutical (BMRN) | 1.7 | $44M | 506k | 87.78 | |
Eli Lilly & Co. (LLY) | 1.6 | $42M | 493k | 84.11 | |
Shire | 1.6 | $40M | 231k | 174.23 | |
Pfizer (PFE) | 1.5 | $39M | 1.1M | 34.21 | |
Thermo Fisher Scientific (TMO) | 1.4 | $35M | 228k | 153.60 | |
Teva Pharmaceutical Industries (TEVA) | 1.3 | $33M | 1.0M | 32.09 | |
CVS Caremark Corporation (CVS) | 1.2 | $32M | 412k | 78.50 | |
Humana (HUM) | 1.2 | $32M | 154k | 206.14 | |
AmerisourceBergen (COR) | 1.1 | $29M | 331k | 88.50 | |
iShares NASDAQ Biotechnology Index (IBB) | 0.9 | $23M | 78k | 293.27 | |
IDEXX Laboratories (IDXX) | 0.8 | $21M | 132k | 154.61 | |
Neurocrine Biosciences (NBIX) | 0.8 | $19M | 446k | 43.30 | |
Novartis (NVS) | 0.7 | $19M | 249k | 74.27 | |
Molina Healthcare (MOH) | 0.7 | $18M | 403k | 45.60 | |
McKesson Corporation (MCK) | 0.7 | $17M | 113k | 148.26 | |
SPDR S&P Biotech (XBI) | 0.6 | $16M | 227k | 69.34 | |
Sabra Health Care REIT (SBRA) | 0.6 | $15M | 551k | 27.93 | |
GlaxoSmithKline | 0.6 | $15M | 359k | 42.16 | |
Omega Healthcare Investors (OHI) | 0.6 | $15M | 459k | 32.99 | |
Sarepta Therapeutics (SRPT) | 0.6 | $15M | 512k | 29.60 | |
Paratek Pharmaceuticals | 0.6 | $15M | 763k | 19.25 | |
AstraZeneca (AZN) | 0.6 | $14M | 464k | 31.14 | |
Sanofi-Aventis SA (SNY) | 0.5 | $14M | 305k | 45.25 | |
Senior Housing Properties Trust | 0.5 | $13M | 647k | 20.25 | |
Medical Properties Trust (MPW) | 0.5 | $13M | 1.0M | 12.89 | |
Welltower Inc 6.50% pfd prepet | 0.5 | $13M | 200k | 63.12 | |
CIGNA Corporation | 0.5 | $12M | 84k | 146.50 | |
Zimmer Holdings (ZBH) | 0.5 | $13M | 102k | 122.11 | |
Alnylam Pharmaceuticals (ALNY) | 0.5 | $13M | 244k | 51.25 | |
Exelixis (EXEL) | 0.5 | $12M | 552k | 21.67 | |
Merus N V (MRUS) | 0.5 | $12M | 479k | 24.38 | |
Charles River Laboratories (CRL) | 0.4 | $11M | 127k | 89.95 | |
Ventas (VTR) | 0.4 | $11M | 176k | 65.04 | |
Health Care SPDR (XLV) | 0.4 | $11M | 141k | 74.36 | |
Physicians Realty Trust | 0.4 | $11M | 531k | 19.87 | |
Centene Corporation (CNC) | 0.4 | $10M | 144k | 71.26 | |
Endo International | 0.4 | $10M | 915k | 11.16 | |
Pieris Pharmaceuticals | 0.4 | $10M | 3.9M | 2.60 | |
Aegerion Pharmaceuticals 2% Du cvbond | 0.4 | $10M | 13M | 0.80 | |
Bristol Myers Squibb (BMY) | 0.4 | $10M | 187k | 54.38 | |
Acadia Healthcare (ACHC) | 0.4 | $10M | 231k | 43.60 | |
Galapagos Nv- (GLPG) | 0.4 | $10M | 116k | 86.19 | |
Puma Biotechnology (PBYI) | 0.4 | $9.7M | 260k | 37.20 | |
Tetraphase Pharmaceuticals | 0.4 | $9.2M | 1.0M | 9.19 | |
Care Cap Properties | 0.4 | $9.3M | 345k | 26.87 | |
Cytomx Therapeutics (CTMX) | 0.3 | $9.2M | 530k | 17.27 | |
Akorn | 0.3 | $7.9M | 328k | 24.08 | |
Ardelyx (ARDX) | 0.3 | $8.1M | 639k | 12.65 | |
Adaptimmune Therapeutics (ADAP) | 0.3 | $8.1M | 1.5M | 5.51 | |
Karyopharm Therapeutics (KPTI) | 0.3 | $7.8M | 605k | 12.84 | |
Natera (NTRA) | 0.3 | $7.8M | 882k | 8.87 | |
Cellectis S A (CLLS) | 0.3 | $7.4M | 310k | 24.00 | |
Momenta Pharmaceuticals | 0.3 | $6.7M | 504k | 13.35 | |
Pra Health Sciences | 0.3 | $6.7M | 102k | 65.23 | |
LTC Properties (LTC) | 0.2 | $6.5M | 136k | 47.90 | |
Sage Therapeutics (SAGE) | 0.2 | $6.4M | 91k | 71.07 | |
Global Blood Therapeutics In | 0.2 | $6.4M | 173k | 36.85 | |
Cardinal Health (CAH) | 0.2 | $6.2M | 77k | 81.55 | |
Epizyme | 0.2 | $6.2M | 362k | 17.15 | |
Universal Health Services (UHS) | 0.2 | $6.0M | 48k | 124.45 | |
United Therapeutics Corporation (UTHR) | 0.2 | $6.0M | 44k | 135.37 | |
Dex (DXCM) | 0.2 | $6.0M | 71k | 84.73 | |
Ultragenyx Pharmaceutical (RARE) | 0.2 | $6.0M | 88k | 67.78 | |
Flamel Technologies Sa | 0.2 | $6.0M | 624k | 9.68 | |
Hca Holdings (HCA) | 0.2 | $5.6M | 63k | 88.99 | |
New Senior Inv Grp | 0.2 | $5.8M | 568k | 10.20 | |
Dermira | 0.2 | $5.6M | 165k | 34.11 | |
Egalet Corporation note 5.50% 4/1/20 | 0.2 | $5.7M | 7.0M | 0.82 | |
Edwards Lifesciences (EW) | 0.2 | $5.3M | 56k | 94.08 | |
Foamix Pharmaceuticals | 0.2 | $4.6M | 930k | 4.95 | |
Myovant Sciences | 0.2 | $4.7M | 400k | 11.74 | |
Bluebird Bio (BLUE) | 0.2 | $4.5M | 49k | 90.89 | |
Allergan Plc pfd conv ser a | 0.2 | $4.2M | 5.0k | 849.80 | |
Affimed Therapeutics B V | 0.1 | $3.2M | 1.4M | 2.30 | |
Innoviva (INVA) | 0.1 | $3.4M | 249k | 13.83 | |
Amicus Therapeutics (FOLD) | 0.1 | $3.0M | 419k | 7.13 | |
Grifols S A Sponsored Adr R (GRFS) | 0.1 | $3.1M | 166k | 18.87 | |
Retrophin | 0.1 | $3.1M | 168k | 18.46 | |
Beigene | 0.1 | $3.2M | 88k | 36.62 | |
Novo Nordisk A/S (NVO) | 0.1 | $2.8M | 83k | 34.28 | |
Tenet Healthcare Corporation (THC) | 0.1 | $2.9M | 165k | 17.71 | |
Mallinckrodt Pub | 0.1 | $2.8M | 62k | 44.57 | |
Nabriva Therapeutics | 0.1 | $2.8M | 233k | 11.99 | |
Halozyme Therapeutics (HALO) | 0.1 | $2.6M | 200k | 12.96 | |
Perrigo Company (PRGO) | 0.1 | $2.5M | 37k | 66.38 | |
Forward Pharma A/s | 0.1 | $2.6M | 123k | 21.51 | |
Healthcare Realty Trust Incorporated | 0.1 | $2.2M | 68k | 32.50 | |
Accelr8 Technology | 0.1 | $2.4M | 100k | 24.20 | |
Nanostring Technologies (NSTGQ) | 0.1 | $2.3M | 114k | 19.87 | |
Horizon Pharma | 0.1 | $2.4M | 163k | 14.78 | |
Dbv Technologies S A | 0.1 | $2.3M | 66k | 35.21 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $2.2M | 287k | 7.80 | |
Valeant Pharmaceuticals Int | 0.1 | $2.1M | 192k | 11.03 | |
Dynavax Technologies (DVAX) | 0.1 | $2.1M | 345k | 5.95 | |
Diplomat Pharmacy | 0.1 | $2.1M | 130k | 15.95 | |
Arca Biopharma | 0.1 | $2.0M | 811k | 2.50 | |
Community Health Systems (CYH) | 0.1 | $1.8M | 204k | 8.87 | |
Coherus Biosciences (CHRS) | 0.1 | $1.9M | 90k | 21.16 | |
Impax Laboratories | 0.1 | $1.6M | 124k | 12.65 | |
HCP | 0.1 | $1.4M | 46k | 31.27 | |
Acceleron Pharma | 0.1 | $1.4M | 55k | 26.46 | |
Healthcare Tr Amer Inc cl a | 0.1 | $1.4M | 46k | 31.46 | |
Welltower Inc Com reit (WELL) | 0.1 | $1.5M | 21k | 70.84 | |
GenMark Diagnostics | 0.1 | $1.2M | 93k | 12.82 | |
Uniqure Nv (QURE) | 0.1 | $1.4M | 241k | 5.78 | |
Juno Therapeutics | 0.1 | $1.3M | 57k | 22.20 | |
Xenon Pharmaceuticals (XENE) | 0.1 | $1.4M | 350k | 4.00 | |
Spark Therapeutics | 0.1 | $1.3M | 24k | 53.33 | |
Intellia Therapeutics (NTLA) | 0.0 | $1.0M | 72k | 14.09 | |
Novavax | 0.0 | $731k | 571k | 1.28 | |
Alliqua | 0.0 | $825k | 1.7M | 0.50 | |
Auris Med Hldg | 0.0 | $713k | 775k | 0.92 | |
Bellicum Pharma | 0.0 | $740k | 60k | 12.33 | |
Flex Pharma | 0.0 | $713k | 162k | 4.40 | |
Global Medical Reit (GMRE) | 0.0 | $666k | 73k | 9.07 | |
Allscripts Healthcare Solutions (MDRX) | 0.0 | $600k | 47k | 12.68 | |
Xencor (XNCR) | 0.0 | $478k | 20k | 23.90 | |
Celldex Therapeutics | 0.0 | $382k | 106k | 3.61 | |
Rmr Group Inc cl a (RMR) | 0.0 | $368k | 7.4k | 49.46 | |
Quorum Health | 0.0 | $129k | 24k | 5.44 | |
Abbvie (ABBV) | 0.0 | $10k | 156.00 | 64.10 | |
Zafgen | 0.0 | $62k | 13k | 4.66 |